ClinVar Miner

Submissions for variant NM_022068.3(PIEZO2):c.1528-1G>A (rs1555648288)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000579242 SCV000681213 likely pathogenic not provided 2017-12-07 criteria provided, single submitter clinical testing The c.1528-1G>A variant in the PIEZO2 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This splice site variant destroys the canonical splice acceptor site in intron 12. It is predicted to cause abnormal gene splicing resulting in an in-frame protein product with an abnormal message. The c.1528-1G>A variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.1528-1G>A as a likely pathogenic variant.
Undiagnosed Diseases Network,NIH RCV000625966 SCV000746564 likely pathogenic Arthrogryposis, distal, with impaired proprioception and touch 2017-12-11 criteria provided, single submitter clinical testing This splice site mutation is categorized as deleterious according to ACMG guidelines (PMID: 18414213) and was found in trans with another variant (c.5083-1G>A) in a 6-year-old female with ataxia, hypotonia, mild dysmorphic features, delayed motor development, scoliosis. It is predicted to cause abnormal gene splicing resulting in an in-frame protein product with an abnormal message.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.